Operant conditioning is a ubiquitous but mechanistically poorly understood form of associative learning in which an animal learns the consequences of its behavior. Using a single-cell analog of operant conditioning in neuron B51 of Aplysia, we examined second-messenger pathways engaged by activity and reward and how they may provide a biochemical association underlying operant learning. Conditioning was blocked by Rp-cAMP, a peptide inhibitor of PKA, a PKC inhibitor, and by expressing a dominant-negative isoform of Ca 2+ -dependent PKC (apl-I). Thus, both PKA and PKC were necessary for operant conditioning. Injection of cAMP into B51 mimicked the effects of operant conditioning. Activation of PKC also mimicked conditioning but was dependent on both cAMP and PKA, suggesting that PKC acted at some point upstream of PKA activation. Our results demonstrate how these molecules can interact to mediate operant conditioning in an individual neuron important for the expression of the conditioned behavior.
INTRODUCTION
Operant conditioning (Thorndike, 1911; Skinner, 1938) and classical conditioning (Pavlov, 1927) are two major forms of associative learning, and they are exhibited by all animals, including humans. Operant conditioning involves an association between a behavior and its consequence. Classical conditioning involves an association between a typically neutral stimulus and a subsequent more salient stimulus. The cellular and molecular mechanisms of classical conditioning have been explored in great depth (Lechner and Byrne, 1998; Schafe et al., 2001; Christian and Thompson, 2003) . In contrast, although operant conditioning has been studied extensively in many different animal model systems (Hoyle, 1979; Cook and Carew, 1989; Botzer et al., 1998; Reynolds et al., 2001; Kelley, 2004) , little is known about the molecular mechanisms that underlie this form of learning even in the invertebrate model systems, which have proven so useful for molecular analyses of sensitization and classical conditioning (e.g., Kandel, 2001) . Some progress has been made in analyzing mechanisms of appetitive operant conditioning in rodents. For example, appetitive instrumental learning is impaired by blocking D1-type dopamine receptors (Smith-Roe and Kelley, 2000) or inhibition of cAMP-dependent protein kinase within the nucleus accumbens (Baldwin et al., 2002) . However, the complete signaling pathways have not been elucidated nor is it known how these signaling cascades mediate the associative convergence between the behavior and reward signals. A better understanding of the molecular mechanisms of appetitive operant conditioning is essential for a deeper understanding of reward-related learning and may provide insight into related disorders, such as addiction. Furthermore, a mechanistic understanding of operant conditioning allows for a comparison between the molecular mechanisms of these two major forms of associative learning.
Feeding behavior of the marine mollusk Aplysia can be operantly conditioned with an appetitive protocol. The neural circuitry that underlies feeding is well characterized and amenable to biophysical and biochemical analyses. Appetitive operant conditioning of ingestive feeding behavior leads to an increase in the expression of this behavior, and that increase is associated with changes in the biophysical properties of neuron B51 (Brembs et al., 2002) . B51 is a ''decision-making'' neuron that displays an all-or-nothing several second level of activity, which is denoted as a plateau potential (Plummer and Kirk, 1990) . The threshold for eliciting the plateau potential is decreased and the input resistance is increased following in vivo operant training (Brembs et al., 2002) . B51 is critical for the expression of ingestive behavior (Nargeot et al., 1999a (Nargeot et al., , 1999b Mozzachiodi et al., 2008) , and both changes to the membrane properties of B51 make the cell more likely to generate a plateau potential, which can contribute to the conditioned increase in the expression of ingestive behavior. Furthermore, the ganglia that contain the circuitry necessary for generating the feeding response can be removed from naive animals and be successfully trained with an in vitro analog of operant conditioning in which fictive ingestion is contingently reinforced with an esophageal nerve shock (Nargeot et al., 1997) . The esophageal nerve likely mediates the food reward signal (Lechner et al., 2000; Brembs et al., 2002) and is rich with dopamine-containing fibers (Kabotyanski et al., 1998) . This in vitro training protocol produces an increase in fictive ingestion and, as was also the case with the in vivo conditioning, an increase in the input resistance of B51 and a decrease in its burst threshold (Nargeot et al., 1999a) . Burst activity in B51 is pivotal for the expression of the reinforced behavior, so it can be used as a substitute for the behavior in the training protocol. Indeed, if plateau potentials generated in B51 are contingently reinforced with esophageal nerve shock, then the input resistance and the burst threshold of B51 are altered in the same way as with the previous training protocols, and fictive feeding is increased (Nargeot et al., 1999b) . Also, in vitro operant conditioning can be blocked by using a dopamine receptor antagonist (Nargeot et al., 1999c) , indicating that the reward signal is likely mediated by dopamine.
Because the behavior can be represented by activity in B51 and the reinforcement can be represented with dopamine, the in vitro analog can be reduced to the level of a single cell. B51 can be isolated and placed in cell culture. Plateau potentials can be used as the analog of behavior, and dopamine can be iontophoretically applied to B51 as the analog of reinforcement ( Figure 1A ). This single-cell analog of operant conditioning produces the same increase in the input resistance of B51 and the same decrease in the burst threshold, as observed with the previous operant training methods (Brembs et al., 2002) . Moreover, applying dopamine in a noncontingent manner does not alter the membrane properties of B51 (Brembs et al., 2002) . From the behaving animal, to the neural network, to the level of the single cell, the same changes in the membrane properties of B51 are consistently observed following each operant protocol, justifying the reductionist approach. In the present report, we exploited the advantages of the single-cell analog to investigate the molecular mechanisms underlying operant conditioning.
RESULTS

Contingent
Reinforcement with a D1 Dopamine Receptor Agonist Mimics Conditioning Dopamine appears to mediate the reward signal in this example of operant reward learning similar to its role in many other model systems (Schultz, 2002) . Single-cell PCR was used to examine whether the Aplysia D1-like dopamine receptor was expressed in B51. As illustrated by the band in the left lane of Figure 1B , the mRNA for the D1-like receptor was detected in B51, which was confirmed by a negative control (right lane, Figure 1B ) with RNase treatment of the cellular contents prior to the reverse transcriptase reaction, which showed only a faint band remaining. Furthermore, a D1-dopamine receptor antibody revealed that the receptors were localized to the axon hillock region of B51 ( Figure 1C ). This localization is consistent with an observation that, during conditioning, the tip of the dopamine-containing iontophoretic electrode needed to be positioned near the axon hillock region of B51 to elicit a response in the membrane potential ( Figure 1D) . A similar response in the membrane potential of B51 was observed if the D1 receptor agonist chloro-APB (Barbas et al., 2006) was iontophoresed onto B51 ( Figure 1D ). To further test the hypothesis that a D1-like dopamine receptor mediates reinforcement, we replicated the original findings of the singlecell analog of operant conditioning (Brembs et al., 2002) by iontophoresing chloro-APB onto B51 in place of dopamine. Two experimental groups were examined. In one group, seven plateau potentials were each contingently reinforced with brief iontophoretic puffs of chloro-APB. The second group received the same amount of chloro-APB, but it was not contingent on the expression of a plateau potential. Contingently reinforcing activity with chloro-APB produced an increase in the input resistance and a decrease in the burst threshold of B51 as compared to the noncontingent control (Figures 1E and 1F) , and these results are similar to previous results obtained when dopamine is used as the reinforcement (Brembs et al., 2002; see also Figures 2, 7, 8) .
cAMP Is Necessary for the Single-Cell Analog of Operant Conditioning The D1-like dopamine receptors in B51 are likely coupled to adenylyl cyclase and increase the production of cAMP when dopamine is bound (Barbas et al., 2006) . Therefore, cAMP and PKA are likely to be important elements of the intracellular signaling cascade underlying reinforcement. To test the hypothesis that cAMP is necessary for the conditioning, Rp-8-Br-cAMPS (RpcAMP) was used to block the cAMP pathway during conditioning. Three experimental groups were examined. In one group, seven plateau potentials were each contingently reinforced with dopamine delivery. A second group received the same contingent reinforcement protocol but in the presence of 2 mM bath-applied Rp-cAMP. The third group received the same application of Rp-cAMP but in the absence of plateau potentials or reinforcement. Contingent reinforcement decreased the burst threshold ( Figures 2A1 and 2A3 ) and increased the input resistance of B51 ( Figures 2B1 and 2B3 ), similar to previous observations (Nargeot et al., 1999a (Nargeot et al., , 1999b Brembs et al., 2002) . Rp-cAMP by itself did not appear to appreciably alter the membrane properties of B51. However, the effects of conditioning were blocked in the presence of 2A3, 2B2, and 2B3) . Thus, the cAMP cascade appeared to be necessary for the conditioning, and cAMP appears to act via PKA, because a peptide inhibitor for PKA also blocked the conditioning (see Figure 7) .
In order to monitor the activation of PKA by the single-cell analog of operant conditioning, we used an antibody against Aplysia CREB1 peptide with the target residue for PKA, Ser 85 , phosphorylated (Mohamed et al., 2005) . Immediately after training with the single-cell analog, cells were processed to measure the immunoreactivity for phospho-CREB1. Cells that received contingent reinforcement had significantly higher levels of phospho-CREB1 as compared to cells that received noncontingent reinforcement ( Figure 2C ). Because the PKA site on CREB1 could have been phosphorylated by a kinase other than PKA, we repeated the experiment in the presence of Rp-cAMP to validate the use of the phospho-CREB1 assay as an indicator of activation of the cAMP/PKA pathway. In the presence of RpcAMP, the increase in the level of phospho-CREB1 normally seen following contingent reinforcement was blocked ( Figure 2C ). These results indicate that the single-cell analog induced a rapid phosphorylation of CREB1 at a PKA site, which suggests that PKA was activated by contingent reinforcement.
PKC Is Necessary for the Single-Cell Analog of Operant Conditioning The next step was to determine the second messenger cascade elicited by the analog of the behavior. One possibility is that Ca 2+ entry during the plateau potential (Plummer and Kirk, 1990) activates PKC similar to how burst firing in an Aplysia sensory neuron activates PKC (Jones et al., 2001) . In fact, the Ca 2+ -dependent PKC isoform apl-I can be translocated from the cytosol to the plasma membrane, where PKC becomes active, with Ca 2+ influx alone (Zhao et al., 2006) . This Ca 2+ -dependent isoform of PKC was detected in B51 ( Figure 3A) . A fusion protein of PKC apl-I and EGFP was expressed in B51, and bath application of 1 mM of the Ca 2+ ionophore ionomycin caused translocation of PKC apl-I from the cytosol of B51 to the plasma membrane ( Figure 3C ). There are some regions of the cell depicted in Figure 3C1 where the translocation appears to be internal to the plasma membrane. However, the majority of translocation appears to be at the plasma membrane, which is supported by the summary data in Figure 3C2 . Also, modest translocation of PKC from the cytosol to the plasma membrane was observed following a single plateau potential in B51 ( Figure S1 available online). However, iontophoresing dopamine with the same parameters as with the single-cell analog did not appear to cause any translocation of PKC (data not shown). The Ca
2+
-independent isoform PKC apl-II was not detected in B51 ( Figure 3A) , although our PCR primers were able to detect this isoform in sensory neurons of Aplysia ( Figure 3A) . To test the hypothesis that PKC is involved in the conditioning, bisindolylmaleimide I (Bis) was used to inhibit PKC during conditioning. Three experimental groups were examined. One group received the contingent reinforcement protocol. Another group received the same (A) Light micrograph of B51 after 5 days in primary cell culture. Using conventional current-clamp techniques, it was possible to record and stimulate plateau potentials in the cell while iontophoresing dopamine onto the cell. (B) Single-cell PCR was conducted using individual B51 neurons. PCR primers were designed to detect the Aplysia D1-dopamine receptor. This receptor was expressed in B51, as the band of DNA detected was the expected size based on the primer design. Also, a negative control with RNase treatment of the cellular contents prior to the reverse transcriptase reaction showed only a faint band. (C) Distribution of D1-like dopamine receptors in B51. Confocal imaging of a cultured B51 neuron incubated with an Aplysia D1-like dopamine receptor antibody showed that the receptor localized to the membrane of B51 near the axon hillock (arrowhead; n = 4). (D) Both dopamine and the D1 dopamine receptor agonist chloro-APB produced a transient depolarization in the membrane potential of B51. Dopamine or chloro-APB was applied extracellularly to the axon hillock region of a cultured B51 neuron. The dopamine or chloro-APB was delivered with iontophoresis in the same way as with the single-cell analog of operant conditioning (200 mM dopamine or 100 mM chloro-APB in iontophoretic electrode; 35 nA amplitude; 6 s duration). (E and F) Contingent reinforcement with a D1 agonist increased the excitability of B51. (E1 and E2) Burst threshold. Representative intracellular recordings from B51 illustrating the measurement of the burst threshold before and after contingent reinforcement with the D1 agonist chloro-APB (E1) and the noncontingent control (E2). (E3) Summary data illustrating that the decrease in B51 burst threshold was significantly greater in neurons contingently reinforced with the D1 agonist (n = 4) as compared to the noncontingent control (n = 4; Mann-Whitney, p < 0.05). (F1 and F2) Input resistance. Representative intracellular recordings from B51 illustrating the measurement of the input resistance before and after contingent reinforcement with the D1 agonist chloro-APB (F1) and the noncontingent control (F2). (F3) Summary data illustrating that the increase in B51 input resistance was significantly greater in neurons contingently reinforced with the D1 agonist (n = 4) as compared to the noncontingent control (n = 4; Mann-Whitney, p < 0.05). The bar graphs display means ± SEM. contingent reinforcement protocol, but in the presence of 10 mM bath-applied Bis. The third group received the same application of Bis, but in the absence of plateau potentials or reinforcement. Contingent reinforcement again produced the typical decrease in burst threshold ( Figure 2A4 ) and increase in input resistance ( Figure 2B4 ). Although Bis by itself did not appear to appreciably alter the membrane properties of B51, the effects of conditioning were blocked in the presence of Bis ( Figures 2A4 and 2B4) . Thus, PKC appears to be necessary for the conditioning.
cAMP Mimics the Conditioning in a PKC-Independent Manner Both PKC and PKA appear to be essential elements underlying operant conditioning. The two kinases could act either in series Representative intracellular recordings from a cell that received contingent reinforcement (CR) alone and from a cell that received CR in the presence of bathapplied Rp-cAMP. Depolarizing current pulses were injected into B51 until the cell produced a plateau potential. (A3) Summary data for Rp-cAMP. A significant difference was observed among the three groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the burst threshold was significantly greater in the CR-alone group (n = 4) compared to either the CR + RpcAMP group (n = 4; Student-Newman-Keuls, p < 0.05) or the Rp-cAMP-alone group (n = 4; StudentNewman-Keuls, p < 0.05), indicating that the decrease in the burst threshold produced by CR was blocked by the presence of Rp-cAMP. (A4) Summary data for Bis. The PKC inhibitor Bis was applied using the same protocol. A significant difference was observed among the three groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the burst threshold was significantly greater in the CR-alone group (n = 4) compared to either the CR + Bis group (n = 4; Student-Newman-Keuls, p < 0.05) or the Bis-alone group (n = 4; Student-Newman-Keuls, p < 0.05), indicating that the decrease in the burst threshold produced by CR was blocked by the presence of Bis. (B) Input resistance. (B1 and B2) Intracellular recordings from the same two cells displayed in (A). Hyperpolarizing current pulses were injected into B51 to measure the input resistance. (B3) Summary data for Rp-cAMP. A significant difference was observed among the three groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the input resistance was significantly greater in the CR-alone group (n = 4) compared to either the CR + Rp-cAMP group (n = 4; Student-Newman-Keuls, p < 0.05) or the RpcAMP-alone group (n = 4; Student-NewmanKeuls, p < 0.05), indicating that the increase in the input resistance produced by CR was blocked by the presence of Rp-cAMP. (B4) Summary data for Bis. A significant difference was observed among the three groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the input resistance was significantly greater in the CR-alone group (n = 4) compared to either the CR + Bis group (n = 4; Student-Newman-Keuls, p < 0.05) or the Bis-alone group (n = 4; Student-Newman-Keuls, p < 0.05), indicating that the increase in the input resistance produced by CR was blocked by the presence of Bis. (C) Elevated levels of phospho-CREB1 in B51 produced by the single-cell analog of operant conditioning. (C1) Representative confocal images from B51 neurons immediately after training with contingent reinforcement, the noncontingent control, or contingent reinforcement in the presence of Rp-cAMP. Phospho-CREB1 was localized to the nucleus. (C2) Summary data for phospho-CREB1 levels. A significant difference was observed among the three groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that that phospho-CREB1 levels were higher immediately after training with contingent reinforcement (n = 4) as compared to either the noncontingent control (n = 4; Student-Newman-Keuls, p < 0.05) or contingent reinforcement in the presence of Rp-cAMP (n = 4; Student-NewmanKeuls, p < 0.05). The bar graphs display means ± SEM. or in parallel. They could act in parallel if both kinases need to phosphorylate a common substrate at different sites, which would then lead to the modulation of B51 ( Figure 4A ). Alternatively, the kinases could act in series if PKC phosphorylates some molecule upstream of the activation of PKA (e.g., adenylyl cyclase), causing an increased activation of PKA when the reward signal is given, which would be necessary to enact the changes in B51 ( Figure 4B ). Another way for the kinases to act in series is if the PKC activation is involved somewhere downstream of PKA activation ( Figure 4C ). To test these hypotheses, activators of PKA and PKC were used in concert with the inhibitors Rp-cAMP and Bis.
First, cAMP was injected into cultured B51 neurons. The cAMP injection elicited the same decrease in burst threshold (Figures 5A1 and 5A4) and increase in input resistance (Figures 5B1 and 5B4) as observed with conditioning previously (Nargeot et al., 1999a (Nargeot et al., , 1999b Brembs et al., 2002) , whereas injecting a group of B51 neurons with vehicle did not appreciably alter the membrane properties ( Figures 5A2, 5A4 , 5B2, and 5B4). The cAMP injection alone was sufficient to mimic the conditioning, which likely rules out the parallel pathway hypothesis ( Figure 4A ). A third group consisted of B51 neurons injected with cAMP while being bathed in 10 mM of the PKC inhibitor Bis. This PKC inhibitor, at the same concentration used to block the contingent reinforcement ( Figures 2A4 and 2B4 ), did not block the changes in the membrane properties elicited by cAMP ( Figures 5A3, 5A4 , 5B3, and 5B4). Thus, the modulation of the membrane properties by cAMP appears to be independent of the activation of PKC, which likely excludes the pathway illustrated in Figure 4C , where PKC acts downstream of cAMP synthesis.
Activating PKC Mimics the Conditioning in a cAMP-Dependent Manner If cAMP and PKC are acting in series during this form of operant reward learning and PKC acts upstream of cAMP synthesis, then it is possible that PKC phosphorylates adenylyl cyclase, increasing the production of cAMP and priming it for an enhanced activation if dopamine is delivered soon thereafter ( Figure 4B ). Some isoforms of adenylyl cyclase exhibit this type of PKC sensitivity such as type II (Jacobowitz et al., 1993; Zimmermann and Taussig, 1996; Bol et al., 1997a Bol et al., , 1997b ) and type V (Kawabe Single-cell PCR was conducted using individual B51 or sensory neurons (SN). (A) PCR primers were designed to detect the apl-I and apl-II isoforms of PKC. The apl-I isoform was detected in B51, as the band of DNA shown in the first lane was the expected size based on the primer design. Also, a negative control with RNase treatment of the cellular contents prior to the reverse transcriptase reaction showed no bands. However, the apl-II isoform of PKC was not detected in B51, but we were able to detect it in sensory neurons. (B) PCR primers were designed to detect the three known Aplysia isoforms of adenylyl cyclase (ACaplA, ACaplB, and ACaplC). The A and the B isoforms were detected in B51, as the bands of DNA shown in the first and second lanes were the expected size based on the primer design. Also, a negative control with RNase treatment of the cellular contents prior to the reverse transcriptase reaction showed no bands. The C isoform was not detected in B51, but we were able to detect it in sensory neurons. (C) Ca 2+ entry alone was sufficient for translocation to the B51 plasma membrane of the Ca 2+ -dependent apl-I isoform of PKC. (C1) Representative confocal images from B51 neurons expressing a fusion protein of PKC apl-I with EGFP both before (left panel) and 2 min after (right panel) the bath application of the Ca 2+ ionophore ionomycin (1 mM).
The Ca 2+ entry induced the translocation of PKC apl-I to the plasma membrane, where it becomes activated. (C2) Summary data (n = 3) illustrating that the translocation of PKC was significantly greater 2 min after 1 mM ionomycin treatment as compared to immediately before the treatment (paired t test, p < 0.05). The bar graphs display means ± SEM. et al., 1994, 1996) . Three isoforms of adenylyl cyclase (A, B, and C) have been identified in Aplysia (sequence data available through accession numbers AY843025-7). Single-cell PCR was performed to determine which of these isoforms are expressed in B51 ( Figure 3B ). The A and B isoforms of adenylyl cyclase were detected in B51, whereas C was not. The C isoform could be detected in sensory neurons of Aplysia. The A isoform is most closely related to the type I adenylyl cyclase, which is a Ca 2+ / calmodulin-sensitive form, whereas the B isoform is most closely related to the type II adenylyl cyclase, which displays a high degree of PKC sensitivity (Jacobowitz et al., 1993; Zimmermann and Taussig, 1996; Bol et al., 1997a Bol et al., , 1997b . To test the model depicted in Figure 4B , it is necessary to verify that PKC mimics the conditioning and that it engages the cAMP/PKA pathway in B51. To test this hypothesis, PDAc (2 mM) was bath applied to cultured B51 neurons. After 5 min, the PDAc application produced the same decrease in burst threshold (Figures 6A1 and 6A3) and increase in input resistance (Figures 6B1 and 6B3) as seen in previous conditioning experiments, indicating that a 5 min treatment with PDAc alone was sufficient to mimic the conditioning, whereas 2 min of PDAc treatment was insufficient to alter the membrane properties of B51 (data not shown). Another group of neurons received the same 2 mM treatment of PDAc while being bathed in 2 mM Rp-cAMP. This inhibitor blocked the changes in the membrane properties elicited by PDAc ( Figures 6A2, 6A3 , 6B2, and 6B3). Thus, the ability of PKC to mimic the conditioning was dependent on cAMP, which is consistent with a model ( Figure 4B ) in which PKC acts upstream of cAMP synthesis.
To further examine the possibility that PKC increases the level of cAMP and thereby mimics conditioning, the level of phosphorylated CREB1 (phospho-CREB1) was again monitored as an indicator of the activation of PKA following PDAc treatment. One group of B51 neurons was bathed in 2 mM Rp-cAMP, and another group was bathed in vehicle. Immediately after treatment with PDAc (2 mM, 5 min), the cells were processed to measure the immunoreactivity for phospho-CREB1. PDActreated cells that were bathed in vehicle had significantly higher levels of phospho-CREB1 ( Figures 6C1 and 6C3 ), and this effect was blocked by Rp-cAMP ( Figures 6C2 and 6C3) . These results indicate that PDAc induced a rapid phosphorylation of CREB1 at a PKA site. This effect was blocked by Rp-cAMP, which suggests that the ability of the PDAc treatment to phosphorylate the PKA site is cAMP dependent. Interestingly, both the single-cell analog ( Figure 2C ) and PDAc treatment ( Figure 6C ) (A) The parallel pathway hypothesis. In this model, both PKA (activated by the reward pathway) and PKC (activated by the behavior) are required to jointly phosphorylate a common substrate (e.g., an ion channel protein) that would then cause the increase in the input resistance (R in ) and the decrease in the burst threshold (T b ). (B) The series pathway hypothesis with PKC acting upstream. If PKA and PKC are not acting in parallel, then they would be acting in series. In this model, a plateau potential in B51 produces an accumulation of Ca 2+ in the cell, which can lead to the activation of PKC. The PKC then phosphorylates adenylyl cyclase and primes it for enhanced synthesis of cAMP. The reward signal is mediated by dopamine and likely acts through adenylyl cyclase to increase the production of cAMP. If the ingestive behavior had just preceded the delivery of the reward and adenylyl cyclase was phosphorylated by PKC, then there would be an even greater increase in the production of cAMP over that which would be seen after either behavior alone or dopamine alone. After a sufficient number of contingent reinforcements of behavior with the reward, the increased levels of cAMP would activate PKA sufficiently enough to produce the changes in the membrane properties.
(C) The series pathway hypothesis with PKC acting downstream. In this model, the behavior and the reinforcement converge at adenylyl cyclase again with the Ca 2+ influx from the plateau potential acting in place of the PKC to enhance the production of cAMP when the behavior is contingently reinforced. The increase in PKA would then initiate a cascade resulting in the downstream activation of PKC, which would then lead to the changes in the membrane properties.
appeared to increase the levels of phospho-CREB1 to a similar degree.
Subthreshold Doses of Phorbol and Dopamine Can Combine to Mimic Conditioning
As a further test of the synergistic actions of the PKC and dopamine pathways, we examined the combinatorial effects of subthreshold application of phorbol with dopamine. The modulation of the membrane properties of B51 was examined under three conditions. First, to activate the reward pathway, dopamine was applied (seven evenly spaced iontophoretic puffs of dopamine during a 10 min period) in the same manner as during the single-cell analog, but in the absence of the burst activity in B51. Next, subthreshold doses of PDAc (500 nM, 10 min) were applied to mimic activation of the behavior/activity pathway. Finally, the two manipulations were applied together on an additional group of cultured B51 neurons. Neither the subthreshold phorbol treatment nor the dopamine treatment alone was able to modulate the membrane properties of B51 ( Figure 6D ). However, when subthreshold phorbol and DA were applied together, the input resistance of B51 increased and the burst threshold decreased ( Figure 6D ), which is an effect identical to that produced by the single-cell analog of operant conditioning ( Figures 1E, 1F , 2A, and 2B).
A Peptide Inhibitor of PKA also Blocks the Conditioning
The previous experiments indicate that cAMP is necessary for the conditioning. To further examine whether PKA is necessary for the conditioning, we used the specific peptide inhibitor PKI-A (6-22; Bao et al., 1998) . B51 neurons were injected either with PKI-A or vehicle and then subjected to the single-cell analog of operant conditioning. After performing the single-cell analog, the neurons were treated with the same phorbol treatment that mimicked the conditioning (Figure 6 ), to test whether PKI-A could also block the PDAc treatment effect. Also, because the singlecell analog was performed just prior to PDAc treatment in the vehicle group, it was possible to examine whether the singlecell analog could occlude the effect of PDAc treatment. The PKI-A treatment blocked the changes in the membrane properties of B51 normally induced by either the single-cell analog or PDAc (Figure 7 ), indicating that cAMP mediates its effects on input resistance and burst threshold through PKA rather than through a PKA-independent pathway. Also, in the vehicle group, the prior treatment of B51 with the single-cell analog occluded the effects of PDAc treatment (Figure 7) , indicating that the phorbol treatment acts on input resistance and burst threshold through the same mechanism as the single-cell analog.
The Ca 2+ -Dependent Isoform of PKC Is Necessary for Conditioning, but Not the Ca 2+ -Independent Isoform
To determine which isoform of PKC is mediating the conditioned changes in B51, we used dominant-negative isoforms of both PKC apl-I and PKC apl-II (Manseau et al., 2001 ). B51 neurons were injected with vectors encoding for either dominantnegative PKC apl-I or PKC apl-II and then subjected to the single-cell analog of operant conditioning. After performing the single-cell analog, the B51 neurons were treated with the same phorbol treatment that mimicked the conditioning (Figure 6 ), to test whether dominant-negative PKC could also block the effect of PDAc treatment. The dominant-negative isoform of the Ca 2+ -dependent PKC (apl-I) blocked the conditioned changes in B51 normally induced by either the single-cell analog or PDAc (Figure 8 ), indicating that this isoform was necessary for the conditioning. In contrast, the dominant-negative isoform of the Ca 2+ -independent PKC (apl-II) did not block the conditioning in B51 by the single-cell analog. This negative result is unlikely to be due to ineffectiveness of the dominant-negative isoform of PKC apl-II. It has been previously shown to inhibit PKC-dependent facilitation of sensorimotor synapses in Aplysia (Manseau et al., 2001) . Also, the PDAc treatment effect was blocked in this group, likely Representative intracellular recordings from a cell that received an iontophoretic injection of cAMP, a cell that received vehicle injection, and from a cell that received cAMP injection in the presence of bath-applied Bis. Depolarizing current pulses were injected into B51 until the cell produced a plateau potential. (A4) Summary data. A significant difference was observed among the three groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the burst threshold was significantly greater in both the cAMP group (n = 4; Student-Newman-Keuls, p < 0.05) and the cAMP + Bis group (n = 4; Student-Newman-Keuls, p < 0.05) compared to the vehicle-injected group (n = 4). (B) Input resistance. (B1-B3) Intracellular recordings from the same cells displayed in (A). Hyperpolarizing current pulses were injected into B51 to measure the input resistance. (B4) Summary data. A significant difference was observed among the three groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the input resistance was significantly greater in both the cAMP group (n = 4; Student-Newman-Keuls, p < 0.05) and the cAMP + Bis group (n = 4; Student-Newman-Keuls, p < 0.05) compared to the vehicle-injected group (n = 4). The bar graphs display means ± SEM.
Neuron Molecular Mechanisms of Operant Conditioning
because the single-cell analog occluded it in the same way as in Figure 7 . The alternative explanation that the PDAc effect was blocked by the dominant-negative PKC apl-II is unlikely because PKC apl-II is not detected in B51 ( Figure 3A) .
DISCUSSION
During operant conditioning of feeding behavior, an Aplysia learns the consequences of its behavior. Because the behavior can be represented by activity in B51 and the reinforcement can be represented by dopamine, the in vitro analog can be reduced to the level of a single cell. Using this reduced system, we found that both cAMP and PKC were necessary and sufficient for the conditioning. Our data are consistent with a model ( Figure 4B ; see also Figure S2 ) of the molecular mechanisms of operant conditioning in which there is a convergence (at some point upstream of cAMP production) of an activity-induced signaling cascade involving Ca 2+ -dependent PKC apl-I and a D1
receptor-induced signaling cascade. One likely point of convergence is the adenylyl cyclase complex. Contingent activation of the two pathways would lead to larger production of cAMP than that produced by either pathway alone. Under normal conditions, the cAMP produced by activity alone or DA alone is insufficient to raise the level of cAMP past some threshold for inducing the cellular changes in B51. In contrast, repeated contingent reinforcements raise the level of cAMP greater than that produced by either pathway alone, so that the cAMP level exceeds the threshold for producing the changes in B51. Although convergence is normally required to produce sufficient cAMP to induce the cellular changes, direct intracellular injection of cAMP ( Figure 5 ) presumably raised the levels of cAMP past the threshold necessary to induce the cellular changes in B51. Similarly, application of PDAc (2 mM, 5 min), used to mimic the activity pathway, would produce the cellular changes in B51 ( Figure 6 ) because it would lead to a much greater increase in cAMP levels than that normally produced by activity alone (B51 plateau potentials have a duration of only 5-15 s). The model was corroborated by experimental evidence showing that phospho-CREB1 levels were significantly greater following contingent training as compared to the noncontingent . Phospho-CREB1 was localized to the nucleus. (C3) Summary data illustrating that phospho-CREB1 levels were higher immediately after PDAc treatment and that this effect is blocked by Rp-cAMP (Mann-Whitney, p < 0.05). (D) Effects of subthreshold application of PDAc (500 nM) and DA. (D1) Burst threshold. A significant difference was observed among the three groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the burst threshold was significantly decreased in the PDAc + DA group (n = 4) compared to either the PDAc-alone group (n = 4; Student-Newman-Keuls, p < 0.05) or to the DAalone group (n = 4; Student-Newman-Keuls, p < 0.05). (D2) Input resistance. A significant difference was observed among the three groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the input resistance was significantly increased in the PDAc + DA group (n = 4) compared to either the PDAc-alone group (n = 4; Student-Newman-Keuls, p < 0.05) or to the DA-alone group (n = 4; Student-Newman-Keuls, p < 0.05). The bar graphs display means ± SEM. control group ( Figure 2C ). Immediately after training, cells that received contingent reinforcement had significantly higher levels of phospho-CREB1 as compared to cells that received noncontingent reinforcement or to cells that received contingent reinforcement in the presence of Rp-cAMP. These results indicate that the single-cell analog induced a rapid phosphorylation of CREB1 at a PKA site, which suggests that PKA was activated by contingent reinforcement. This result is consistent with the model of Figure 4B , in which contingent training produces a greater increase in cAMP than noncontingent training. Also, the increase in the levels of phospho-CREB1 is consistent with the induction of long-term memory, which has been observed with this form of conditioning in B51 (Mozzachiodi et al., 2008) . With a parallel model (see Figure 4A ), the level of activation of the cAMP/PKA pathway would be similar with either contingent or noncontingent reinforcements of plateau potentials with DA. However, this is clearly not the case, because phospho-CREB1 levels are significantly higher with contingent reinforcement than with the noncontingent control ( Figure 2C ).
Increased training-induced phosphorylation of CREB1 was mimicked by phorbol treatment and this effect was blocked by Rp-cAMP (Figure 6 ), which suggested that PKC activated the cAMP/PKA pathway. Phorbol treatment alone has been shown to raise the levels of cAMP in cells containing type II-like adenylyl cyclase (Jacobowitz et al., 1993; Zimmermann and Taussig, 1996; Bol et al., 1997a Bol et al., , 1997b . For example, Jacobowitz et al. (1993) found that phorbol treatment alone induced an $3-fold increase in cAMP production, forskolin treatment alone produced an $6-fold increase in cAMP, and the two together produced an $12-fold increase. These results indicate that converging (A and B) Representative intracellular recordings from B51 illustrating the measurement of the burst threshold (A) and the input resistance (B) before and after both the single-cell analog (SCA) and subsequent PDAc treatment (2 mM) of cells injected with either PKI-A (A1 and B1) or vehicle (A2 and B2). In this example, the burst threshold decreased in the vehicle-treated group from 0.7 nA to 0.3 nA following contingent reinforcement. However, when the same cell was subsequently treated with PDAc, the burst threshold did not change (0.3 nA before treatment and 0.3 nA after treatment), illustrating the occlusion effect. A similar occlusion effect was also observed with the input resistance. (C) Summary data. (C1) Burst threshold. A significant difference was observed among the four groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the burst threshold was significantly greater in the single-cell analog/ vehicle group (n = 4) as compared to the PDAc/vehicle group (n = 4; Student-Newman-Keuls, p < 0.05), the single-cell analog/PKI-A group (n = 4; Student-Newman-Keuls, p < 0.05), or the PDAc/PKI-A group (n = 4; Student-NewmanKeuls, p < 0.05). (C2) Input Resistance. A significant difference was observed among the four groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the input resistance was significantly greater in the single-cell analog/vehicle group (n = 4) as compared to the PDAc/vehicle group (n = 4; Student-NewmanKeuls, p < 0.05), the single-cell analog/PKI-A group (n = 4; Student-Newman-Keuls, p < 0.05), or the PDAc/PKI-A group (n = 4; Student-Newman-Keuls, p < 0.05). Thus, the PKI-A peptide blocked the conditioned changes in B51 normally resulting from the both the single-cell analog and PDAc treatment. Also, the single-cell analog appeared to occlude the effects of PDAc treatment. The bar graphs display means ± SEM. interaction between PKC and Gs can synergistically activate the adenylyl cyclase to produce levels of cAMP that are much higher than with either treatment alone. In addition, a direct assay of cAMP production in Aplysia sensory neuron clusters (Sugita et al., 1997) showed a significant increase in cAMP following phorbol treatment, indicating that a type II-like adenylyl cyclase is present in Aplysia. B51 expresses an isoform of adenylyl cyclase with homology to the type II isoform ( Figure 3B ). Moreover, phorbol treatment in B51 mimicked the conditioning after 5 min of bath application (Figure 6 ), whereas 2 min of treatment was insufficient. The effects of PDAc take time to develop and were blocked by blocking the actions of cAMP and PKA, suggesting that PDAc application led to slowly developing activation of the cAMP/PKA pathway. A significant difference was observed among the four groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the burst threshold was significantly greater in the single-cell analog/ dominant-negative PKC apl-II group (n = 4) as compared to the PDAc/dominant-negative PKC apl-II group (n = 4; Student-Newman-Keuls, p < 0.05), the single-cell analog/dominant-negative PKC apl-I group (n = 4; Student-NewmanKeuls, p < 0.05), or the PDAc/dominant-negative PKC apl-I group (n = 4; Student-Newman-Keuls, p < 0.05). (C2) Input Resistance. A significant difference was observed among the four groups (Kruskal-Wallis, p < 0.05). A post hoc analysis revealed that the change in the input resistance was significantly greater in the single-cell analog/ dominant-negative PKC apl-II group (n = 4) as compared to the PDAc/dominant-negative PKC apl-II group (n = 4; Student-Newman-Keuls, p < 0.05), the single-cell analog/dominant-negative PKC apl-I group (n = 4; Student-NewmanKeuls, p < 0.05), or the PDAc/dominant-negative PKC apl-I group (n = 4; Student-Newman-Keuls, p < 0.05). Thus, the expression of the dominantnegative PKC apl-I isoform blocked the conditioned changes in B51 normally resulting from the both the single-cell analog and PDAc treatment. Also, the single-cell analog again appeared to occlude the effects of PDAc treatment. The bar graphs display means ± SEM.
Additional support for the model of Figure 4B was provided by experiments showing that the changes produced by either PDAc application or the single-cell analog of operant conditioning were blocked by Rp-cAMP (Figures 2 and 6 ) or by intracellular injection of a highly specific peptide inhibitor of PKA (PKI-A) (Figure 7) . Moreover, the changes produced by either PDAc application or the single-cell analog were blocked by expressing a dominant-negative isoform of the Ca 2+ -dependent PKC but not by a dominant-negative isoform of the Ca 2+ -independent PKC (Figure 8 ). The observation that cAMP alone is sufficient to produce the changes in the membrane ( Figure 5 ) excludes a parallel model (e.g., Figure 4A ) where PKA and PKC would be required to jointly phosphorylate distinct sites on their putative common substrate molecule. However, this observation does not rule out a model where PKA and PKC can both phosphorylate the same site on their putative common substrate molecule. In this single-site parallel model, either PKA or PKC could activate the substrate sufficiently alone, if they were at a high enough level, or they could combine to provide the necessary level of phosphorylation. The observation that the phorbol-induced modulation of the membrane properties can be suppressed by blocking cAMP/PKA (Figure 6 ) is supportive of a model in which the actions of cAMP are downstream of PKC ( Figure 4B ), excluding the model depicted in Figure 4C and also excluding the single-site parallel model ( Figure 4A ). In that parallel model, the phorbol treatment would still activate PKC, which would still be able to phosphorylate and fully activate the putative common substrate, even if the cAMP/PKA pathway is blocked, but this does not occur. Rather, the observation that blocking cAMP/PKA blocks the phorbol-induced changes in the membrane, likely indicates that phorbol/PKC modulates the membrane properties by activating cAMP/PKA (i.e., the model depicted in Figure 4B , not the parallel model). The notion that phorbol/PKC activates cAMP/PKA is also supported by the observation that phorbol treatment increases the levels of phospho-CREB1 ( Figure 6C ) similar to the single-cell analog ( Figure 2C ) and the increase in phospho-CREB1 levels by either phorbol treatment, or the single-cell analog is blocked by RpcAMP ( Figures 2C and 6C ), indicating that the phosphorylation is cAMP dependent. Also, the phorbol effect was occluded by prior conditioning with the single-cell analog (Figure 7 ), indicating that they likely operate through a common pathway. Interestingly, the mechanisms of activity-dependent neuromodulation for this appetitive form of operant conditioning appear to be very similar to a form of aversive classical conditioning observed in sensory neurons of Aplysia, which mediate withdrawal reflexes (Lechner and Byrne, 1998) . In the sensory neuron, the coincidence detection involves, at least in part, a synergistic interaction between a Ca 2+ /calmodulin-sensitive adenylyl cyclase (type I) and a serotonin-activated cAMP cascade (Ocorr et al., 1985; Yovell et al., 1992) . Also, in Drosophila, a type I adenylyl cyclase that is necessary for classical conditioning does not appear to be necessary for operant conditioning (Brembs and Plendl, 2008) . Although the specific isoform of adenylyl cyclase appears to differ (type I for classical conditioning and type II for operant conditioning), adenylyl cyclase appears to serve as the molecule of convergence in both forms of learning. This finding is striking but does not imply that adenylyl cyclase is a universal coincidence detector for all examples of classical and operant conditioning. Indeed, the membrane properties of B51 were also modulated by classical conditioning (Lorenzetti et al., 2006) . However, following classical conditioning, the burst threshold of B51 increases rather than decreases as it does following operant conditioning, and the input resistance does not change, indicating that the mechanisms underlying the modulation of B51 by classical conditioning involve a different as yet unidentified coincidence detector from that for operant conditioning. Because dopamine likely mediates both the unconditioned stimulus (US) of classical conditioning and the reinforcement of operant conditioning (Kabotyanski et al., 1998; Nargeot et al., 1999c; Brembs et al., 2002; Reyes et al., 2005) , a key problem is to elucidate the mechanisms that lead to the induction of opposite effects on the burst threshold. One possibility is that the coincidence detector for classical conditioning involves an association between a transmitter released by the conditioned stimulus (CS) and the dopamine-mediated reward pathway, whereas for operant conditioning, the coincidence detector, as shown in the present study, likely involves an association between PKC and the dopamine-mediated reward pathway. Exploring these pathways and their interactions will provide important insights into the molecular logic of operant and classical conditioning.
Growing evidence indicates that many of the same molecular pathways that mediate operant conditioning in Aplysia are also involved in vertebrate reward learning in the striatum. For example, in vivo operant conditioning was blocked by infusions into the nucleus accumbens of antagonists for D1 dopamine receptors and NMDA receptors (Smith-Roe and Kelley, 2000) and also by inhibitors of cAMP/PKA (Baldwin et al., 2002) . Furthermore, D1 dopamine receptors are necessary for potentiation of cortico-striatal synapses in an analog of reward learning where induced electrical activity in striatal spiny neurons was paired with reward-inducing stimulation of the substantia nigra (Reynolds et al., 2001) . In addition to synaptic plasticity, striatal spiny neurons can display an increased level of intrinsic excitability known as the up-state. Increasing CREB levels in the nucleus accumbens increased the intrinsic excitability of spiny neurons mimicking the up-state, and blocking CREB decreased the excitability (Dong et al., 2006) . Also, a recent study in Drosophila has shown that PKC may play a role in operant conditioning (Brembs and Plendl, 2008) . The Aplysia feeding system, however, offers several distinct advantages for investigating the molecular mechanisms of reward learning. Many of the circuit elements have been identified in the neuronal network responsible for Aplysia feeding behavior. This work has established a functional role for B51 during feeding and demonstrates how the modulation of the membrane properties of B51 following conditioning can modulate the behavioral response. Furthermore, knowing how B51 is activated during feeding behavior and the nature of the reinforcement has enabled the construction of the single-cell analog of operant conditioning. The analog, in turn, has provided access to the cellular and molecular processes underlying the learning and has enabled the elucidation of the how these molecular pathways interact and converge to mediate operant conditioning in an individual neuron important for the expression of the conditioned behavior.
EXPERIMENTAL PROCEDURES Animals
Aplysia californica (80-130 g) were obtained from Alacrity Marine Biological Specimens (Redondo Beach, CA) and Marinus Scientific (Long Beach, CA). Animals were housed in perforated plastic cages floating in aerated seawater tanks at a temperature of 15 C. Animals were fed $1 g of dried seaweed three times per week.
Cell Culture Culturing procedures followed those described in Schacher and Proshansky (1983) , Rayport and Schacher (1986) , Chin et al. (1999) , and Brembs et al. (2002) ; also (see Supplemental Experimental Procedures).
Immunohistochemistry
An affinity-purified rabbit polyclonal antibody for the Aplysia D1-like dopamine receptor (Barbas et al., 2006) was raised in rabbits against a peptide fragment 12 amino acids long from the third extracellular loop of the protein (Genemed Synthesis, San Francisco, CA). Also, an affinity-purified rabbit polyclonal antibody for Aplysia phospho-CREB1 (Mohamed et al., 2005) 
Single-Cell Analog
The procedures for the single-cell analog have been described previously (Brembs et al., 2002 ; also see Supplemental Experimental Procedures). Briefly, the cultured B51 neurons received seven evenly spaced suprathreshold depolarizing current pulses in a 10 min training period. The induced plateau potentials were contingently reinforced with a 6 s iontophoretic pulse of dopamine (Sigma, St. Louis, MO) immediately after the cessation of the plateau potential, whereas iontophoresis was delayed by 40 s in the noncontingent group. The single-cell analog was also performed by iontophoresing the D1 dopamine receptor agonist chloro-APB (100 mM; Sigma, St. Louis, MO) instead of dopamine.
To test the role of PKA and PKC, the membrane-permeable inhibitors Rp-8-Br-cAMPS (Rp-cAMP, Biolog, Bremen, Germany) and bisindolylmaleimide I (Bis, Calbiochem, La Jolla, CA) were individually bath applied to cultured B51 neurons (Liao et al., 1999; Kabir et al., 2001 ). The Rp-cAMP and Bis were applied for 30 min prior to the start of the single-cell analog, and the inhibitor was maintained in the bath throughout the experiment. After the 30 min incubation, the membrane properties were measured, the single-cell analog was performed, after which the membrane properties were retested. The experimenter was blind to whether the inhibitors were present or not. All membrane property measurements are displayed as the percent difference between the post-test and pre-test values normalized to the pre-test. All recordings were performed at room temperature ($20 C-22 C).
cAMP Injection cAMP was iontophoresed with a fine-tipped double-barrel glass microelectrode. One barrel contained the standard recording solution of 2 M potassium acetate, whereas the other barrel was used for iontophoresis and contained 150 mM cAMP, 200 mM KOH, 20 mM Tris HCl, with pH adjusted to 7.4. The concentration of cAMP in the iontophoretic electrode was similar to what has been used previously in Aplysia (Walsh and Byrne, 1989) . A square wave current pulse of À10 nA for 10 s was used to eject the cAMP. Another group of cells received the same treatment as above, except instead of cAMP, a vehicle solution containing 200 mM KOH, 20 mM Tris HCl, with pH adjusted to 7.4 was in the iontophoretic barrel of the electrode. A third group of cells was bathed in 10 mM Bis for 30 min prior to cAMP injection. Next, cAMP was iontophoresed into the cell, as above. The experimenter was blind to whether cAMP or vehicle was present in the iontophoresing electrode. For more detail, see Supplemental Experimental Procedures.
Phorbol Esters
Cultured B51 neurons were current clamped at À80 mV for the duration of the experiment. Five minutes after impalement, input resistance and burst threshold were measured. Next, phorbol diacetate (PDAc, Sigma, St. Louis, MO), a membrane-permeable activator of PKC, was bath applied to a final concentration of 2 mM, similar to what has been used previously in Aplysia (Sugita et al., 1997) . The input resistance and the burst threshold were measured again after 5 min of PDAc application. Another group of cells was bathed in 2 mM RpcAMP for 30 min and then given the same protocol as described above, with the membrane properties being measured both before and after PDAc application. The experimenter was blind to whether the Rp-cAMP was present or not.
In a separate experiment, seven evenly spaced iontophoretic puffs of dopamine were delivered to cultured B51 neurons during a 10 min phase, with the same parameters as with the single-cell analog of operant conditioning (but with no plateau potentials). The membrane properties of B51 were measured both before and after the 10 min phase of dopamine application. Next, subthreshold doses of PDAc (500 nM) were applied to these cultured B51 neurons. The membrane properties were tested before application and both 5 and 10 min after the application. Neither 5 nor 10 min of PDAc (500 nM) application appreciably altered the membrane properties of B51. A separate group of cultured B51 neurons were then simultaneously given the subthreshold PDAc treatment along with the seven iontophoretic puffs of dopamine in 10 min. The membrane properties were measured both before and after this 10 min phase.
PKC Translocation
Plasmids encoding for the Ca 2+ -dependent PKC apl-I fused with EGFP (Zhao et al., 2006) were generously provided by Dr. Wayne Sossin (McGill University). The plasmids (1.5 mg/ml) were pressure injected into the nucleus of cultured B51 neurons 1 day prior to imaging to allow time for the proteins to express. The plasmids were coinjected with TRITC dye to monitor the success of the injection, and protein expression was verified by EGFP fluorescence. Images were obtained with a Bio-Rad 1024 MP confocal microscope using a 603 oilimmersion lens and consisted of 10-15 mm optical sections. The section through the middle of the nucleus was used for analysis of mean fluorescence intensities by Metamorph imaging software (Molecular Devices Corp., Sunnyvale, CA). Translocation of PKC was monitored following either bath application of the Ca 2+ ionophore ionomycin (1 mM; Sigma, St. Louis, MO), dopamine iontophoresis (same parameters as with the single-cell analog), or a plateau potential in B51. The translocation observed with ionomycin application was quantified by calculating the ratio of the average intensity at the plasma membrane over the average intensity in the cytoplasm. Average intensity measurements for the plasma membrane and the cytoplasm were calculated by measuring the average intensity from three randomly placed rectangles in each region.
Dominant-Negative PKC
Plasmids encoding for dominant-negative isoforms of the Ca
2+
-dependent and Ca 2+ -independent PKC apl-I and apl-II fused with EGFP (Zhao et al., 2006) were generously provided by Dr. Wayne Sossin (McGill University). The plasmids (1.5 mg/ml) were pressure injected into the nucleus of cultured B51 neurons 1 day prior to training to allow time for the proteins to express. The plasmids were coinjected with TRITC dye to monitor the success of the injection, and protein expression was verified by EGFP fluorescence. The cultured B51 neurons expressing either dominant-negative PKC apl-I or apl-II were then subjected to the single-cell analog of operant conditioning as described previously, which was then followed by 5 min of 2 mM PDAc treatment. The experimenter was blind to whether the neuron was injected with dominant-negative PKC apl-I or apl-II.
PKI-A
The PKA peptide inhibitor PKI-A (6-22, Sigma, St. Louis, MO) was pressure injected into the cytoplasm of cultured B51 neurons just prior to conditioning. The concentration of PKI-A in the electrode was 500 mM, and the peptide was coinjected with TRITC dye to monitor the success of the injection. Half of the B51 neurons received PKI-A and the other half were injected with vehicle. The cultured B51 neurons were then subjected to the single-cell analog of operant conditioning as described previously, which was then followed by 5 min of 2 mM PDAc treatment. The experimenter was blind to whether the neuron was injected with PKI-A or vehicle.
PCR
Single-cell PCR was performed using cultured individual B51 neurons or sensory neurons (positive control) as the source of the template RNA. A negative control was also performed with the template RNA digested by ribonuclease A (Sigma, St. Louis, MO) prior to the reverse transcriptase reaction. The PCR primers were designed from the published sequences of the Aplysia D1 dopamine receptor, Aplysia PKC isoforms apl-I and apl-II, and the three known Aplysia isoforms of adenylyl cyclase. For more detail, see Supplemental Experimental Procedures.
Statistical Analysis
All values were expressed as means ± SEM. Statistical significance was set at p < 0.05, and all statistical tests were two tailed. For more detail, see Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and figures and can be found with this article online at http://www.neuron.org/ cgi/content/full/59/5/815/DC1/.
